These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9924360)

  • 1. Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy.
    Chantelau E
    Br J Ophthalmol; 1998 Jul; 82(7):725-30. PubMed ID: 9924360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of serum IGF-1 rather than sex steroids precedes proliferative diabetic retinopathy in Mauriac's syndrome.
    Chantelau E; Seppel T; Althaus C; Schönau E
    Horm Res; 1997; 48(3):131-4. PubMed ID: 11546930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of diabetic retinopathy during improved metabolic control may be treated with reduced insulin dosage and/or somatostatin analogue administration -- a case report.
    Chantelau E; Frystyk J
    Growth Horm IGF Res; 2005 Apr; 15(2):130-5. PubMed ID: 15809016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of serum IGF-1 precedes proliferative diabetic retinopathy in Mauriac's syndrome.
    Chantelau E; Eggert H; Seppel T; Schönau E; Althaus C
    Br J Ophthalmol; 1997 Feb; 81(2):169-70. PubMed ID: 9059256
    [No Abstract]   [Full Text] [Related]  

  • 5. Progression of diabetic retinopathy and changes in serum insulin-like growth factor I (IGF I) during continuous subcutaneous insulin infusion (CSII).
    Hyer SL; Sharp PS; Sleightholm M; Burrin JM; Kohner EM
    Horm Metab Res; 1989 Jan; 21(1):18-22. PubMed ID: 2925151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between glycaemic control and serum insulin-like growth factor 1 on the risk of retinopathy in type 2 diabetes.
    Chen HS; Wu TE; Hsiao LC; Lin SH
    Eur J Clin Invest; 2012 Apr; 42(4):447-54. PubMed ID: 22050075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion of 'early worsening' of diabetic retinopathy by deliberate restoration of poor metabolic control.
    Chantelau E; Meyer-Schwickerath R
    Ophthalmologica; 2003; 217(5):373-7. PubMed ID: 12913330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin analogues may accelerate progression of diabetic retinopathy after impairment of inner blood-retinal barrier.
    Kaya A; Kar T; Aksoy Y; Özalper V; Başbuğ B
    Med Hypotheses; 2013 Dec; 81(6):1012-4. PubMed ID: 24090664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables.
    Henricsson M; Berntorp K; Berntorp E; Fernlund P; Sundkvist G
    Diabetes Care; 1999 Dec; 22(12):1944-9. PubMed ID: 10587823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome).
    Daneman D; Drash AL; Lobes LA; Becker DJ; Baker LM; Travis LB
    Diabetes Care; 1981; 4(3):360-5. PubMed ID: 7047112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Decreased serum level of free bioavailable IGF-I in patients with diabetic retinopathy].
    Feldmann B; Lang GE; Arnavaz A; Jehle PM; Böhm BO; Lang GK
    Ophthalmologe; 1999 May; 96(5):300-5. PubMed ID: 10414118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of serum IGF-1 for treatment of early worsening of diabetic retinopathy: a long-term follow-up of two cases.
    Chantelau E; Meyer-Schwickerath R; Klabe K
    Ophthalmologica; 2010; 224(4):243-6. PubMed ID: 19940532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1985 Mar; 290(6471):811-5. PubMed ID: 3919804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IGF-1 concentration in diabetic retinopathy.
    Hyer SL; Sharp PS; Brooks RA; Burrin JM; Kohner EM
    Diabet Med; 1988; 5(4):356-60. PubMed ID: 2968886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Insulin-Like Growth Factor-1 on Diabetic Retinopathy in Pubertal Age Patients With Type 1 Diabetes.
    Raman P; Singal AK; Behl A
    Asia Pac J Ophthalmol (Phila); 2019; 8(4):319-323. PubMed ID: 31369407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
    Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
    Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.